Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
International Society for Gastrointestinal Hereditary Tumours |
RCV000623903 | SCV000740671 | pathogenic | Lynch syndrome 1 | 2018-03-09 | reviewed by expert panel | curation | Class 5 - Pathogenic Classification using multifactorial probability: 0.997 |
Genetics and Molecular Pathology, |
RCV003447545 | SCV004175568 | likely pathogenic | Lynch syndrome | 2021-06-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003594010 | SCV004312666 | pathogenic | Hereditary nonpolyposis colorectal neoplasms | 2024-11-18 | criteria provided, single submitter | clinical testing | This sequence change replaces isoleucine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 276 of the MLH1 protein (p.Ile276Arg). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of Lynch syndrome (external communication, internal data). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 520540). Invitae Evidence Modeling incorporating data from in vitro experimental studies (internal data) indicates that this missense variant is expected to disrupt MLH1 function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects MLH1 function (PMID: 36054288). For these reasons, this variant has been classified as Pathogenic. |